We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Crystallization Aids Study of Neuron Receptors

By Biotechdaily staff writers
Posted on 09 Jun 2002
Researchers using protein crystallization techniques have found that perturbations at the molecular structure level govern desensitization of neurons and reduced response to neurotransmitters. More...
This work, which helps to explain how experimental, memory-enhancing drugs affect the brain on a molecular level, was published in the May 16, 2002, issue of Nature.

"Learning how neurons respond to neurotransmitters is important not only to understanding basic brain functioning, but also may one day lead to new insights into a variety of new therapies,” said Duane Alexander, Director of the National Institute of Child Health and Human Development (Bethesda MD, USA), which conducted the research.

The GLUR2 AMPA-sensitive glutamate receptor, one of the ligand-gated ion channels, was the subject of the study. Investigators took advantage of the fact that after activation many ligand-gated ion channels enter a desensitized state in which the neurotransmitter remains bound but the ion channel is closed. One part of the glutamate receptor was isolated by biochemical methods, and its structure was examined at the atomic level. Researchers then designed altered receptors and determined their atomic structures as well. By observing how experimental drugs interacted with both mutant and normal receptors, they hoped to gain more insights into how the drugs interact with the receptor and into the process of desensitization.

Results showed that receptor activation involves conformational changes within each receptor subunit that produce an increase in the separation of portions of the receptor that are linked to the ion channel. Desensitization occurs through rearrangements that dislocate the ligand-binding core from the ion channel gate.



Related Links:
National Institute of Child Health and Human Development

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.